Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOCUS fluconazole pharmacokinetics in children and adolescents
2021-006868-24Phase 4Active
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fluconazole in invasive mycoses and mycoses (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Population pharmacokinetics of fluconazole, Fluconazole clearance and 4 more. Started Jun 2022; status: active.
02
Drugs
fluconazole
03
Conditions
invasive mycosesmycoses
Beyond the preview
Go deeper on 2021-006868-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006868-24.